Article Details

Autolus and Moderna sign Option and License Agreement for access to proprietary targeting ...

Retrieved on: 2021-08-02 16:41:15

Tags for this article:

Click the tags to see associated articles and topics

Autolus and Moderna sign Option and License Agreement for access to proprietary targeting .... View article details on hiswai:

Excerpt

LONDON, UK I August 02, 2021 I Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up